The ACIP committee has historically operated with a lack of transparency and evidence, necessitating a shift toward rigorous, long-term safety evaluations.

“One is there's a paucity of data that can really be understood and give true um information to parents and those who are taking medicines on what the real risks and benefits and how far we've studied um these vaccines or vaccine products or even monoclonal antibodies to watch for long-term risk.”

Vaccine committee recommendations are often made without adequate data, and this lack of evidence should result in a more cautious, safety-first approach.

“Well, especially not without huge confounders. Like when you try to pull these apart when if you listen to the 2018 ACIP meeting and they were talking about these things, they were talking about combination vaccines. And so, they had already approved what was recommended, and they said they had no d”